CIDRAP newsletters options
EpiVax, Inc., a vaccine development and immune engineering company based in Providence, R.I., yesterday announced it is part of collaboration supported by a $5.8 million award from the National Institutes of Health (NIH) to develop a new type of vaccine against H7N9 avian influenza.
Symbiomix Therapeutics announced yesterday that the US Food and Drug Administration (FDA) on Sep 15 approved its antibiotic Solosec (secnidazole) for treating bacterial vaginosis (BV) in adults, the first single-dose option for the condition.
Researchers at the University of Washington report in Clinical Infectious Diseases that a subclone of the emerging global pathogen Escherichia coli sequence type (ST) 131 is not as prevalent in children as adults but is nearly as dominant in drug-resistant E coli infections in children.
Italy has now confirmed 14 cases of locally acquired chikungunya, 6 of them in Rome, the World Health Organization (WHO) said in a Sep 15 statement.
Hundreds who may have drunk contaminated raw milk may be unaware of the risk.
The case total now stands at 235, with 78 hospitalizations and 2 deaths in 26 states.
Hong Kong's Centre for Health Protection (CHP) today reported a new case of H7N9 avian flu in Liaoning province, further evidence that the virus has not disappeared during the summer.
Results from a new study in Pediatrics confirmed high performance of a novel diagnostic test to distinguish bacterial from viral infection in febrile children.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Study shows no increase in hospitalized sepsis cases over a 5-year period.
The fast, automated assay performs well against gold standard TB tests.
German researchers have found indications that the risk of acquiring healthcare-associated vancomycin-resistant enterococci (HA-VRE) is linked to the use of specific antimicrobial agents, according to a study yesterday in Antimicrobial Resistance and Infection Control.
Pregnant women who received the pandemic H1N1 influenza vaccine in 2009 or 2010 were no more likely to have adverse birth outcomes than women who received the seasonal flu shot at the time, according to a study published yesterday in Vaccine.
Women who had received 2 straight H1N1-containing vaccines had a higher rate of miscarriage.
Nursing homes are likely filled with many resistant organisms interacting with antibiotics and each other.
An experimental malaria drug called AQ-13 compared well with an established combination treatment in a non-inferiority trial in Malian men with non-severe malaria, according to a report yesterday in The Lancet Infectious Diseases.
Although overuse of antimicrobials is a known contributor to antimicrobial resistance in general, researchers reported yesterday they could find no association between numbers of US antimicrobial prescriptions during a recent 8-year period and resistance in the bacteria that causes gonorrhea.
In addition, Oman reports its first MERS case of the year, in a middle-aged man.
Tom Frieden, MD, MPH, who stepped down as the director of the US Centers for Disease Control and Prevention (CDC) at the end of the Obama administration, today announced the launch of a $225 million initiative to combat infectious disease outbreaks and heart disease and stroke throughout the world, according to media reports.
The Biomedical Advanced Research and Development Authority (BARDA) has awarded drug maker Summit Therapeutics $32 million over the next 2 years for development of a new antibiotic for Clostridium difficile infection (CDI).
